CHU Lyon-Sud

Lyon

0 studies enrolling now · 2 studies all time

What they study most

Acute Kidney Injury, Merkel Cell Carcinoma, Necrotizing Soft Tissue Infection, Peritonitis

Studies at this site

• Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma — Status unconfirmed
• Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury — Stopped early